Companies /Healthcare

Palatin Technologies Inc

NYSE ARCA: PTN Biotechnology
$10.09
▼ $0.28 (−2.70%) today
Markets closed · 6:16pm ET
Today · % change

Fundamentals

Market Cap
$18.5M
P/E Ratio
94.3
Profit Margin
-48.5%
Revenue (TTM)
$12.9M
EPS (TTM)
$0.11
52-Week Range
$6 – $31
Street Target
$53.50

About PTN

Palatin Technologies, Inc., a specialty biopharmaceutical company, develops targeted receptor-specific therapies for the treatment of various diseases in the United States. The company is headquartered in Cranbury, New Jersey.

PTN Coverage